Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Sensorion gets EMA’s Agreement on the Pediatric Investigation Plan (PIP) for Arazasetron (SENS-401) in two indications
June 28, 2019 Off

Sensorion gets EMA’s Agreement on the Pediatric Investigation Plan (PIP) for Arazasetron (SENS-401) in two indications

By BusinessWire

Sensorion gets EMA’s agreemtn, which paves the way for the submission of a marketing authorization application in Europe

June 28, 2019 Off

Moody’s Upgrades Bio-Rad to Baa2, Reflecting Recent Improvement in the Company’s Operating Performance

By BusinessWire

HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…

June 28, 2019 Off

ADDING MULTIMEDIA Alexion Receives FDA Approval of SOLIRIS® (eculizumab) for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder (NMOSD) who are Anti-Aquaporin-4 (AQP4) Antibody Positive

By BusinessWire

– At 48 weeks, 98% of patients treated with SOLIRIS were relapse free compared to 63% of patients receiving placebo…

June 28, 2019 Off

Global Biotechnology Leaders Gather in Hong Kong

By BusinessWire

International Science and Technology Innovation Center Forum Nobel and Turing Award Winners Hong Kong Summit HONG KONG–(BUSINESS WIRE)–The first day…

June 27, 2019 Off

Karuna Therapeutics Announces Pricing of Upsized Initial Public Offering

By BusinessWire

BOSTON–(BUSINESS WIRE)–$KRTX–Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric…

June 27, 2019 Off

vTv Therapeutics Initiates Phase 2 Clinical Trial Evaluating Azeliragon in Patients with Mild Alzheimer’s Disease and Type 2 Diabetes

By BusinessWire

HIGH POINT, N.C.–(BUSINESS WIRE)–vTv Therapeutics Inc. (Nasdaq: VTVT) announced today that the first patient has been screened for the phase…

June 27, 2019 Off

vTv Therapeutics Initiates Phase 2 Clinical Trial Evaluating Azeliragon in Patients with Mild Alzheimer’s Disease and Type 2 Diabetes

By BusinessWire

HIGH POINT, N.C.–(BUSINESS WIRE)–vTv Therapeutics Inc. (Nasdaq: VTVT) announced today that the first patient has been screened for the phase…

June 27, 2019 Off

Glaukos Corporation Completes Acquisition of DOSE Medical Corporation

By BusinessWire

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization…

June 27, 2019 Off

Glaukos Corporation Completes Acquisition of DOSE Medical Corporation

By BusinessWire

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization…

June 27, 2019 Off

Columbia Care Enters World’s Largest Regulated Cannabis Market with Grand Opening of Flagship Dispensary in San Diego, California

By BusinessWire

Global medical cannabis leader launches west coast expansion plan in California’s largest, limited license metropolitan market Nationally proven high-touch, provider-based…

Posts pagination

Previous 1 … 3,039 3,040 3,041 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine